Zantac Heartburn Medication
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication Zantac exposes users to unsafe levels of the carcinogen N-Nitrosodimethylamine (NDMA). (Dimesky et al v. Sanofi-Aventis U.S., LLC, Sanofi US Services Inc., Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-1517, D. CT.)
Class-Action Tracker
The Latest
The Rise of ‘Bait-and- Switch Pricing’
Emily Stewart, Business Insider
TINA.org Finds U-Haul Using Bait-and-Switch Pricing Scheme
MADISON, CONN. May 6, 2025 – U-Haul is engaged in a bait-and-switch pricing scheme with its $19.95 truck rental ads, according to an investigation by consumer advocacy organization truthinadvertising.org (TINA.org).…
U-Haul Needs to Pack Up Its Deceptive ‘$19.95’ Truck Ads
TINA.org calls on regulators to stop moving company’s bait and switch.
FTC, Nevada Sue IM Mastery Academy
Complaint alleges IML was a $1.2 billion scam.
OmegaXL: Backed by Research
What you should know about ingredient studies.